Behavior, Addictive
The observable, measurable, and often pathological activity of an organism that portrays its inability to overcome a habit resulting in an insatiable craving for a substance or for performing certain acts. The addictive behavior includes the emotional and physical overdependence on the object of habit in increasing amount or frequency.
Subtype terms (4)
More specific conditions that are subtypes of Behavior, Addictive in the MeSH hierarchy.
Drugs by status
Phase 4 trials (6)
Phase 3 trials (7)
Phase 2 trials (12)
Phase 1 trials (5)
Organizations
Organization Involved with Phase 4 Indications (19)
- Forest Laboratories
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute on Drug Abuse (NIDA)
- Swiss Federal Institute of Technology
- Federal University of Rio Grande do Sul
- George Mason University
- Howard University
- The Mind Research Network
- University of Malaya
- University of Toronto
- Yale University
- University of Zurich
- Creighton University
- State University of New York
- University of California, San Francisco
- Icahn School of Medicine at Mount Sinai
- Center for Addicitve Disorders
- State University of New York, Buffalo
- Government of Ontario
Organization Involved with Phase 3 Indications (31)
- Titan Pharmaceuticals
- Pfizer
- Braeburn Pharmaceuticals
- Catalyst Pharmaceuticals, Inc.
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Cancer Institute (NCI)
- Associação Fundo de Incentivo à Pesquisa
- University of Pennsylvania
- Chang Gung University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- First People's Hospital of Foshan
- Loma Linda University
- National Cheng Kung University
- New York University
- Rhode Island Hospital
- University of South Florida
- Mayo Clinic
- Columbia University
- Taipei Medical University
- University of British Columbia
- Medical University of South Carolina
- US WorldMeds
- University of Sao Paulo
- Mountain Manor Treatment Center, Baltimore MD
- University of Paris
- Department of Veteran Affairs
- Canadian Institutes of Health Research (CIHR)
- Government of Taiwan
- Otrimed Clinical Research
- Nicholson Science
- +1 more
Organization Involved with Phase 2 Indications (26)
- Bioprojet
- National Development and Research Institutes, Inc.
- Teva
- National Institutes of Health (NIH)
- Baylor University
- Johns Hopkins University
- Newcastle University
- Oregon Health and Science University
- Stanford University
- University of Louisville
- University of South Carolina
- University of Tennessee
- Western Michigan University
- University of Copenhagen
- University of Utah
- CHU Brugmann
- University of Minnesota
- Pennsylvania State University
- Free University of Brussels
- University of New South Wales
- Government of Australia
- New York City Department of Health and Mental Hygiene
- China Medical University
- The Novavi outpatient clinics, Copenhagen
- The University of Texas, Dallas
- Aphios
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (9)